Chinese researchers eye anti-AIDS gel

A Chinese man flies a "red ribbon" kite by during an event to commemorate World AIDS Day, in Beijing in 2008. Chinese researchers said Monday they have discovered an HIV-blocking agent that could be developed into a gel to limit the sexual transmission of AIDS.

Chinese researchers said Monday they have discovered an HIV-blocking agent that could be developed into a gel to limit the sexual transmission of AIDS.

Scientists from Hong Kong University said joint research with Shanghai Targetdrug Co., Nanjing University and City University of Hong Kong had discovered a molecule that blocks HIV from entering .

Zhiwei Chen, director of the AIDS Institute of the University of Hong Kong Li Ka Shing Faculty of Medicine, said the potency of the TD-0680 molecule against sexually transmitted HIV was "encouraging".

The new molecule could be developed into a microbicide gel to "prevent HIV " by killing off the virus as it tries to enter the body.

This would give people, especially women, an "alternative method to protect themselves from the virus, in addition to condoms", Chen said.

"The ideal solution is to develop an effective vaccine. Since such a vaccine remains elusive, we must explore other strategies such as topical microbicide," he said.

The TD-0680 molecule is several times more potent than Maraviroc, a Pfizer-developed equivalent which has been approved by the US for clinical treatment, the Chinese scientists said.

Unprotected sex accounts for more than 90 percent of AIDS infections in China, the researchers said in a statement.

Their work was published recently in the peer-reviewed .

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Respect may be the key to stopping patient 'no shows'

20 hours ago

People with HIV are more likely to keep their scheduled medical appointments—and their disease under control—if they feel their physician listens, explains things clearly and knows them as a person, not just a "case," ...

Study details age disparities in HIV continuum of care

Jun 17, 2013

Age disparities exist in the continuum of care for patients with the human immunodeficiency virus (HIV) with people younger than 45 years less likely to be aware of their infection or to have a suppressed viral load, according ...

Cost-effective: Universal HIV testing in India

Jun 10, 2013

In India most people who are HIV positive don't know it, yet testing and treatment are relatively cheap and available. It would therefore meet international standards of cost-effectiveness—and save millions of lives for ...

User comments

More news stories

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...

No danger of cancer through gene therapy virus

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.